Enzymatica AB

📍 Lund, Sweden🗓 Founded 2006👥 21 employees💰 Last funded Apr 2015
Medical Equipment Manufacturing🌐 enzymatica.com
Website LinkedIn
Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme® and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2006
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Enzymatica AB?
Enzymatica AB has 2 investors on record on gritt.io and 2 late-stage investors.
When did Enzymatica AB last raise funding?
The most recent investment in Enzymatica AB recorded on gritt.io was in April 2015.
When was Enzymatica AB founded?
Enzymatica AB was founded in 2006.
What industry is Enzymatica AB in?
Enzymatica AB operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Enzymatica AB based?
Enzymatica AB is headquartered in Lund, Sweden.